Assessment of Right Heart function and dimensions following device closure of Atrial Septal Defect. by Cecily Mary Majella, J
 
 
 
“Assessment of Right Heart functions and   
dimensions following device closure of   
Atrial Septal Defect” 
 
 
Dissertation submitted to 
 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
 
In partial fulfillment of the requirements for the award of the degree of 
 
 
 
D.M. CARDIOLOGY 
BRANCH II – CARDIOLOGY 
 
 
 
MADRAS MEDICAL COLLEGE & 
RAJIV GANDHI GOVERNMENT GENERAL HOSPITAL 
CHENNAI - 600 003 
 
 
 
 
 
 
 
 
 
 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI, INDIA 
 
 
AUGUST 2014 
  
 
 
CERTIFICATE 
 
 
 This is to certify that the dissertation titled “Assessment of 
Right Heart function and dimensions following device 
closure of Atrial Septal Defect” is the bonafide original work of 
Dr.J.Cecily Mary Majella in partial fulfillment of the requirements 
for D.M. Branch-II (CARDIOLOGY) examination of THE 
TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY to be held in 
August 2014. The period of post-graduate study and training was from 
August 2011 to July 2014. 
 
 
 
Prof. R. VIMALA, MD., 
 
Dean 
Rajiv Gandhi Government General 
Hospital & Madras Medical 
College, Chennai – 600 003. 
Prof. M.S.RAVI, M.D, D.M., 
 
Professor and Head of  Department 
Department of Cardiology 
Rajiv Gandhi Government General  
Hospital & Madras Medical College, 
Chennai - 600 003. 
 
 
 
 
 
DECLARATION 
 
 I, Dr.,J.Cecily Mary Majella solemnly declare that this 
dissertation entitled, “Assessment of Right Heart function and 
dimensions following device closure of Atrial Septal Defect” 
is a bonafide work done by me at the department of Cardiology, Madras 
Medical College and Government General Hospital during the period 
2011 – 2014 under the guidance and supervision of the Professor and 
Head of the department of Cardiology of  Madras Medical College and 
Government General Hospital, Professor  M.S.RAVI , M.D., D.M., This 
dissertation is submitted to The Tamil Nadu Dr. M.G.R Medical 
University, towards partial fulfillment of requirement for the award of 
D.M. Degree (Branch-II) in Cardiology. 
 
 
 
 
 
Place:                                          SIGNATURE OF THE CANDIDATE                                                                        
Date: 
  
 
 
ACKNOWLEDGEMENT 
 
 A great many people made this work possible. I thank  
Prof. R.VIMALA, M.D., Dean for allowing me to conduct this study. 
 My warmest respects and sincere gratitude to our beloved Prof. 
M.S.RAVI, M.D., D.M., Professor and Head of the Department of 
Cardiology, Government General Hospital, Chennai who was the driving 
force behind this study. But for his constant guidance this study would 
not have been possible. 
 I am very grateful to Prof K.Meenakshi, Prof. D.Muthukumar, 
Prof. N.Swaminathan, Prof. G.Ravishankar and Prof. Justin Paul 
without whom, much of this work would not have been possible. 
 I acknowledge Dr.S.Venkatesan for his constant support and 
guidance he rendered during this project.  
 I am very much indebted to Prof.G.Gnanavelu for his  
valuable guidance and contribution towards this study              
 I am grateful to, Dr.G.Palanisamy, Dr. Murthy, Dr. G.Manohar 
Dr. S. Murugan, Dr.G.Prathap Kumar, Dr.R.Rajasekar  
Ramesh, Dr.C. Elangovan,  Dr.Arumugam, Dr.Elamaran,  
Dr.Saravana Babu, and Dr.Balaji Pandian for their guidance. 
 I also thank all my patients for their kind cooperation. 
 Lastly, I thank all my professional colleagues for their support and 
valuable suggestions. 
 
 
CONTENTS  
S. 
No. 
Title Page No. 
1. INTRODUCTION 1 
2. AIMS  AND OBJECTIVES 6 
3. REVIEW  OF  LITERATURE 7 
4. MATERIALS AND METHODS 29 
5. RESULTS 31 
6. DISCUSSION 55 
7. CONCLUSION 61 
8. LIMITATION OF STUDY 62 
9. APPENDIX  
 a. Bibliography 
b.  Acronyms 
c. Proforma  
d. Master chart  
e. Ethical committee approval order  
f. Plagiarism Report 
 
 
1 
 
INTRODUCTION  
 Atrial septal defect (ASD) represents one among the most common  
congenital heart disease manifested in adult life. It accounts 7% to 10% 
of all congenital heart disease in children. Ostium secundum being the 
most predominant type and common among females often comes to light 
in young adults
[1].[20]  
 Most of the infants and children presenting with ASD remain   
asymptomatic and clinical examination may be unimpressive, making  
their survival to adulthood as normal as others. The right heart is exposed  
to chronic volume overload due to an increased pulmonary flow 
which leads to dilatation of the right atrium and right  
ventricle (RV
)[1][21].
 Some patients might progress to various stages of  
pulmonary hypertension and right sided heart failure. Patients may  
manifest with dyspnoea, fatigue, recurrent lower respiratory tract 
infection, arrhythmias, and thromboembolic complications. There has 
been consensus by the American Heart Association and European society 
of cardiology that complete closure of the inter atrial communication is 
the management of choice for ASD with significant pulmonary to 
systemic flow ratio, particularly in the presence of right ventricular 
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volume overload along with right atrial and right ventricular dilatation, 
even if the patient has few or no symptoms. 
 Patients who come to medical attention with isolated secundum 
atrial septal defects (ASDs) really benefit from the recent advances in 
optimising the diagnosis, and management
[13,14,23].
. My work will mainly 
focus on adolescents and adult subgroup of patients with optimal sized 
ASDs who do not have other major associated anomalies. 
 The Himalayan progress in the field of interventional cardiology 
has led to the birth of percutaneous device closure of secundum ASD. 
This approach is feasible in around 60–70% of individuals depending on 
the site, and size of defect, the adequacy [at least 5 mm] of all the five 
rims [antero inferior, postero superior, inferior vena caval, superior vena 
caval and aortic rims] and the patient's presenting age
[22]
. The Amplatzer 
septal occluder device has been in use since its inception in 1995
[25]
. After 
undergoing various multicentre randomized clinical trials, the device was 
authenticated and approved by United States of America Food and Drug 
Administration bureau (FDA) in 2002 for use both in children and the 
adult subgroup. For percutaneous transcatheter closure secundum defects 
using Amplatzer septal occluder, added criteria include that the defect 
size is not large for the currently available occluder devices, and ideal 
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distance should prevail so that the device does not encroach the vital 
surrounding structures such as the  aorta ,coronary sinus, right upper 
pulmonary vein ,conduction system and atrioventricular valves .The main 
contraindications for this percutaneous method of device closure of  
secundum defects  include very large defects not amenable for closure or  
smaller and floppy rims  (exception being the anterosuperior  rim of  
aorta).Infants who are symptomatic are usually corrected surgically. 
However, this novel percutaneous method has been successfully 
implemented even in children who weigh 10 kg or less
 [,34]
. Those  who  
are not ideal candidates for device closure is referred for pericardial patch 
closure of the septal  defects  which is done with optimal  results in 
subjects  from  infancy  to even  late adulthood, though it may lead to 
morbidity, and a disfiguring  thoracotomy scar 
[33]
. 
 Right atrial and right ventricular volume overload
[42,43,44]
 are well 
documented consequences of unrepaired atrial septal defects. Persistent 
shunting across the defects, manifesting as right heart enlargement and 
dilatation, may progress to symptomatic disabling arrhythmias. 
 The main of purpose of this study is to assess the right ventricular 
and right atrial size and function and the time they take to normalize after 
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percutaneous device closure of ostium secundum atrial septal defect with 
appropriate sized  septal occluder
[55]. 
 
During the  recent years  percutaneous  closure of  secundum type 
inter atrial  defects were first  implemented  in  clinical practice and  was, 
next to or at par to  surgical procedure, a secure, quite efficient, and  scar 
free option for inter atrial defect closure. Some studies 
[8,10]
 comparing 
transcatheter closure versus surgical closure of septum secundum defects, 
the percutaneous transcatheter option proved superior
[35,36]
. Myocardial 
function evaluation
[60]
, systolic as well as diastolic, was found to be 
impaired by open surgical technique but well preserved after 
percutaneous transcatheter closure. There exists conflicting data on the 
clinical consequences after closure of septal defects as whether they 
actually improve right ventricular function and performance or just 
prevent further deterioration
[59]
. I would quote Eidem et al
 [11][57] 
who 
initially described no significant alteration in right ventricular function in 
patients after surgical closure of inter-atrial septal defects. But, 
Salehian et al
[14][58]
 reported that transcatheter closure of atrial septal 
defect led to improvement of biventricular function. Divergent results 
may suggest that the differences could be due to various closure 
techniques that are being opted and interpatient variabilities
[56]
. 
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 Therefore we analyzed the pre and post procedure dimensions and 
function of   right heart and closely monitored them immediately in the 
post procedure period and followed them at one week, one month, 3 
months after the procedure and also compared them with the surgical 
closure results. 
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AIMS & OBJECTIVES 
 To assess right heart function, right atrial and right ventricular 
dimensions pre and post transcatheter closure of atrial septal defect 
(ASD) and to assess magnitude of resolution of right heart enlargement, 
and   impact on right ventricular function by echocardiography using 2D 
and tissue Doppler imaging.  
 To compare the final outcomes after 3 months of percutaneous 
transcatheter closure of atrial septal defect with that of surgical closure.  
  
7 
 
REVIEW OF LITERATURE 
INTRODUCTION: 
 Leonardo da Vinci wrote, “I’ve found from the left atrium to right 
atrium a perforating channel”. His contribution to true interatrial septal 
defect is known to be the first human record on congenital defects.
[1]
 
Atrial septal defect comprises about 5-10% of all congenital heart 
diseases. It ranks first among the acyanotic congenital heart disease 
presenting in adulthood. Since the clinical presentation and physical 
manifestations are mostly subtle it may go unrecognized and come to 
limelight only in late adulthood. Though in most of the patients survival 
into adult life may be the rule of the day, both quality and expectancy of 
life is impaired in unintervened atrial septal defects, because of the 
longterm impact of volume overload on the right heart geometry and 
function. With expertise, skill, and hardwares constantly improving day 
by day, ASD device closure has now become the foremost mode of 
treatment option for patients with ostium secundum-ASD. However the 
defect size and morphology, and adequacy of rims still remains the 
primary determinant and key to most successful device closure of atrial 
septal defect. 
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ANATOMY AND DEVELOPMENT OF INTERATRIAL SEPTUM: 
 During early development, the heart initially starts of as a single 
atrium. Septum primum normally grows from the atrial roof towards the 
endocardial cushions those results in closure of Foramen primum shunt. 
Foramen secundum is the perforation or fenestration in the middle of the 
thin septum primum, allowing shunt from right to left in fetal life. Septum 
secundum grows down on the right side overlapping the foramen 
secundum. Septum secundum is a crescentic shaped muscular membrane 
arising from ventro-cranial wall of the atrium. Foramen Ovale is guarded 
by the valve of foramen ovale (Septum primum), which normally closes 
functionally by 24 hours, and anatomically by 72 hours. The closure is 
due to the drop in lung pressures after birth and the exceeding pressure in 
the left atrium than that of the right atrium that results in opposition of the 
septum and sealing of defect completely in upto three fourths of the 
infants. The fossa ovalis is as of a saucer shaped depression in the floor of 
septum primum. The limbus of the fossa ovalis is formed from the 
inferior most edge of septum secundum. They occupy 28% of the septal 
area. The interatrial septum when viewed from the right side is like a 
blade in shape and structure with an anterosuperior rim that reflects the 
ascending aortic curvature, mitral annulus which forms the inferior 
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margin, and a convex posterior margin. The left aspect of septum has 
trabecular network which are remnants of primum septum.  
 Interatrial septal aneurysm is due to redundancy of the valve of the 
foramen. These septal aneurysms which represent congenital outpouching 
close to the fossa ovalis may perforate at times resulting in left to right 
shunting. Atrial septal aneurysms constitute approximately 10% of 
individuals undergoing transthoracic echocardiography and around 30% 
of individuals presenting with cryptogenic stroke associated with a 
patency of foramen ovale.The incidence of persistent patency of the 
foramen of ovale ranges from 30-35% during the initial three decades of 
life and declines to 25% from 30-70 years of age. In general, the foramen 
ovale which is patent may result in a right to left and not from left to right 
shunting as occurs when the pressure in right sided atrium exceeds that of 
left as during the strain phase of Valsalva’s maneuver or during general 
straining. 
CLASSIFICATION OF ATRIAL SEPTAL DEFECTS: 
Secundum defect:  
 Being the most common variety constitutes 70-80%. It could be 
single, or multiple, and may be oval rather than circular in     shape. Their 
anatomy is seemingly more complex on the right aspect rather than the 
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left of the septum. These defects are apparently due to deficiency in the 
growth of secundum septum, excessive shortening of foramen ovale 
valve, and lastly due to undue resorption of primum septum. Swiss cheese 
pattern represent multiple small defects usually less than 5 mm. The 
prevalence is twice more common among the female gender more than 
the males. Usually a single defect is present but in 10% of individuals 
more than one defect is present. Approximately, one third of individuals 
may have mitral valve prolapse, or associated congenital malformations 
as pulmonary stenosis, sub aortic stenosis, ventricular septal defects, 
anomalous pulmonary venous drainage in 10%, and coarctation of aorta. 
It can also be associated with acquired heart disease as rheumatic mitral 
stenosis well known by all as the Lutembacher syndrome. Controversy 
exists as whether this syndrome represents only mitral stenosis or it can 
also be associated with acquired mitral regurgitation. 
Primum defect:  
 It comprises 15-20% of the atrial septal defects which involves the 
lower portion of the interatrial septum and typically involves the 
ventricular septum as well as the so called atrio-ventricular canal defect. 
Oddly and very rarely when septal structures remain intact continuity 
exists in the atrioventricular septum. Both the atrio-ventricular valves are 
11 
 
structurally abnormal and the mitral valve is typically cleft giving rise to 
mitral regurgitation of varying degrees. The gender ratio is approximately 
equal in ostium primum type of ASD.  The terminology ostium primum 
does not necessarily characterize the interatrial defect since it is not a 
defect in the interatrial septum, but rather is absence of the atrio-
ventricular septum.  
 Depending on the arrangement and attachment of the bridging 
leaflets the shunt exists at the atrial or ventricular level and when the 
bridging leaflets are not attached to any portion and floating freely 
resulting in shunt both at the atrial and ventricular levels an arrangement 
called as the complete common atrio-ventricular canal. Due to posterior 
displacement of the penetrating bundle which lies in the postero–inferior 
rim of the ventricular component of the defect and the variation in the 
length and activation of the anterior and posterior fascicles explains the 
electro physiologic abnormalities like extreme to moderate left axis 
deviation in these patients.
[1,17]
 These defects are encountered commonly 
in Down syndrome [trisomy 21] and they present frequently early in life 
unlike the septum secundum defects due to their impact on the 
cardiovascular physiology developing congestive cardiac failure earlier 
and even hydrops fetalis. The chief determining factor is the severity of 
left atrio-ventricular regurgitation that may result in a mortality rate of 
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33% within the first year of life. Intractable heart failure may result from 
a hypoplastic left ventricle. Survival into adulthood could be expected 
only in the presence of a competent left atrio-ventricular valve.      
Sinus venosus type of atrial septal defect: 
 These defects are not rare but uncommon and account for  
3-5 %.These defects are positioned just beneath the superior vena cava 
and the right atrial junction and may range from small defects to  
non-restrictive form. The superior vena caval ostium can over-ride the 
septal defect and may be biatrial. This defect is almost always around 
90% associated with partial anomalous pulmonary venous return, usually 
the right upper pulmonary vein or both of the right pulmonary veins 
draining into the right atrium. Because of this location the defect could be 
missed on a trans-thoracic echocardiography, and may require trans-
esophageal echo imaging for proper delineation of the defect. 
Inferior Vena Canal Defect:   
 This is one of the rare forms of Sino-septal defects, which poses 
difficulty in diagnosis and usually missed by trans –thoracic echo and 
may require trans-esophageal echo, or advanced imaging as computed 
tomography or magnetic resonance imaging.
[15,16,21,23] 
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Unroofed coronary sinus: 
 This least form of atrial septal defect is associated with unroofed of 
coronary sinus, leading to shunting of left atrial blood to right atrium. It is 
usually associated with persistent left superior vena cava and anomalous 
pulmonary venous return which could be partial or complete. 
Rims of an Atrial septal defect which are important is assessment of 
suitability of procedure: 
 Antero superior or (aortic rim) 
Antero inferior or (atrio ventricular valve rim) 
Coronary sinus rim 
Infero posterior (inferior vena caval rim) 
Postero superior or (pulmonary vein rim) 
Superior Vena Caval rim     
 Ten   morphological variations: 
• Aortic rim Deficiency (42.1%).  
•  Central deficiency - (24.2%). 
•  Inferoposterior rim deficiency (12.1%). 
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• Septal Aneurysm Perforation (7.9%). 
•  Multiple defects (7.3%). 
•  Deficiency of both mitral and aortic rims (4.1%).  
• Deficiency of Superior Vena Caval rim (1%) and deficiency of 
coronary sinus rim (1%). 
             -Ponder et al 
Inter Atrial Septal Aneursym: 
 If there is excessive tissue in the septum primum and is also very 
weak, and floppy with a maximal   mobility   or excursion   into the atria 
by more than 15 millimeters it is consistent with the diagnosis of septal 
aneurysm of the atrium.
[26]
 Less than 15  millimeters excursion is named 
as – Redundant atrial septum. These aneurysms may coexist with either 
an ostium secundum defect or a patent foramen ovale which by incidence 
in most of the published series is around 60%, making its association 
relatively more common. Recurrent neurological events like transient 
ischemic attack or stroke is more likely to be linked with septal 
aneurysms coexistent with a shunt across the atrial septum. 
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PATHOPHYSIOLOGY: 
 The size of the defect is the key determinant for both the 
magnitude as well as the direction of flow through any septal defects. The 
biventricular compliance is also contributory to these shunts. Conditions 
which alter compliance of the left ventricle such as associated conditions 
like mitral stenosis, or hypertrophy of the ventricle may increase the 
shunt from left  right. Alternatively  conditions that alters the 
compliance  of the right ventricle like  tricuspid stenosis, pulmonary 
stenosis ,and  pulmonary hypertension  which may result in elevated right 
heart pressures  will have opposing hemodynamic  effect of  impeding  
the  left  right shunting and when supersedes   causes  reversal  of  the  
shunt. 
 An ostium secundum defect must be a minimum of at least 10 mm 
diameter as a dictum to produce a hemodynamically significant shunt. 
The interatrial septum is a complex structure and hence not all septal 
defects are circular making the possibility of accurately measuring the 
defect size a cumbersome issue, and thus posing a real challenge to the 
skill of the percutaneous device closure operators who neither visualize 
the septum directly in comparison with the surgical closure technique 
where the operator has the ease of visualizing the septum directly. 
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 A significant leftright shunt is diagnosed when the Qp/Qs ratio is 
more or higher than 1.5/1.0, or it imposes volume overload on the right 
heart leading to dilation of the right heart and impair the long-term 
prognosis.   
CLINICAL FEATURES: 
 Symptoms are usually subtle in most of the patients, though they 
come to limelight at a particular point of time. The age of presentation   is 
a highly indeterminate one and is not attributable entirely to the size of 
the defect alone. Most commonly the individuals present with dyspnea on 
exertion and effort intolerance and easy fatiguability. The chronology of 
the shunt is reflected by the dilated atria that may be a forerunner of 
arrhythmias such as atrial flutter or fibrillation, whose onset has a rapid 
deteriorating effect on the presenting symptoms. Adults may present with 
tricuspid regurgitation and pulmonary hypertension of varying degrees 
progressing to right heart dilatation and failure. A transient ischemic 
attack or an overt stroke may suddenly complicate the clinical scenario 
due to a paradoxical embolism.
[6] 
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DIAGNOSTIC EVALUATION: 
Clinical Examination: 
 Even though there is a day to day progress in the field of advanced 
diagnostic  radiographic tools  like MRI, many  a time an accurate 
diagnosis is missed due to lack of  the dying art of detailed history  taking 
and  clinical examination   which still remains the golden key to unravel 
the diagnosis. Therefore a step wise approach still remains pertinent in 
every single patient. But, of course paucity or absence of clinical findings 
does not rule out a hemodynamically significant atrial septal defect. 
Hence both clinical and radiological evaluation should go hand in hand 
and complement each other. 
 Physical examination may reveal a palpable pulmonary artery 
pulsation, right ventricular parasternal heave or lift, fixed wide split due 
to absence of the differential effects of filling pressures of both sides 
during normal inspiratory fall of intrathoracic pressure.
[18]
 A loud 
pulmonary component of second heart sound may not always be due to 
pulmonary hypertension but may also reflect the increased flow across 
the dilated pulmonary vascular tree which may also produce a systolic 
murmur, and a flow diastolic murmur across the tricuspid valve.    
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 “Crochetage  sign” initially described in 1996 by Heller is the 
characteristic notching  observed  in  apical aspect  of  R  wave in the 
inferior leads resembling the hook of a knitting  needle  may be present 
most commonly with  secundum defects, patent foramen ovale and sinus 
venosus variety of defects. This sign may be present in 30% of ASD 
patients and may reflect the magnitude of shunt with 70% sensitivity and 
90% specificity. The association of this sign with a PFO could be a 
forerunner of impending TIA or stroke. The sensitivity and specificity are 
reportedly high when associated with incomplete RBBB. This sign 
reverts or normalizes in 36% of individuals after closure of the defects.  
Role of Echocardiography in ASD: 
 Precise information in the vast majority 
 Needs to be thorough and systematic 
 Size of the defect 
 Type of   location of ASD 
 Number of ASD’s  
 Right heart and left heart dimensions 
 Right heart and left heart functions 
 Direction of shunt 
 MPA and branch pulmonary artery dimensions and PHT 
assessment and severity
.[19]
  
 Assessment  of  associated valvular  defects 
 Assessment  of  associated  other shunt lesions or cardiac defects 
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 Assessment  of  rims and adequacy[22] 
 Diagnosing associated PAPVC /TAPVC by high index of 
suspicion and expertise skill.  
 Screening for feasibility of intervention 
 Rough estimate of flow ratios Qp/Qs 
 Could give a clue to search for associated syndromes. 
 Monitoring of the procedure 
 Follow-up echocardiography[12,13] 
RIGHT HEART DIMENSION: 
RV DIMENSION:  
 RV dimension is  best evaluated  in  end-diastole  in  a specifically  
focused  apical  four  chamber  view  of the right ventricle. Utmost 
precautions are undertaken to prevent foreshortening of the images which 
is accomplished by viewing the crux of the heart and apex in the same 
image. Diameter of more than 42 millimeter at the basal level and more 
than 35 mm at mid cavity level indicates RV enlargement. Likewise, 
longitudinal or vertical dimension more than 86 millimeters quantifies for 
RV dilatation / enlargement. 
RA DIMENSION: 
 The apical four chamber view is helpful for evaluation of allows 
estimation of the RA measurements. Right atrial  area greater than   
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18 cm
2
,  Right  atrial  major dimension  more than  53 mm, and RA  
minor dimension more than  44 mm  measured  at end-diastole  quantifies 
for RA enlargement. 
RVOT (RV OUTFLOW TRACT MEASUREMENT): 
 The  proximal diameter  measured  in the  proximal part  of  RVOT  
more than  27mm in  end-diastole  PLAX  imaging and  the  distal 
diameter at the level of pulmonary valve insertion more than 33mm is 
diagnostic of  RVOT dilatation. 
RV SYSTOLIC FUNCTION:  
 Systolic function  of  RV
[34,36]
  is assessed by various  parameters, 
such as  TAPSE  (tricuspid annular plane systolic excursion, normal 
>15mm), MPI (myocardial performance index  by Pulsed Doppler  
normal values <0.40 and by  Tissue Doppler  normal values  < 0.55, RV 
FAC (Fractional area change, normal  >35  % ), Ejection fraction using 
both two and three dimensional echo and finally, tricuspid lateral annulus 
peak  systolic velocity by tissue-doppler, strain rate and longitudinal 
strain.
[16]
 Among these, parameters many of the studies have, clearly 
proven the benefit and clinical utility and importance of MPI, and 
TAPSE.
[11]
 Hence we analyzed the right ventricular systolic function 
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using TAPSE, MPI, and isovolumetric acceleration prior to device 
closure and post device closure immediately, and at one week, and three 
months. 
 We also evaluated right atrial dimensions using major and minor 
dimensions ,and right ventricular dimensions using basal, mid and 
longitudinal diameters of right ventricle pre and post device closure at 
follow up of 3 months and compared them with surgical closure.  
TREATMENT: 
 Medical management is usually not necessary preoperatively 
unless congestive symptoms develop which are managed by diuretic 
therapy. Arrhythmias may need medical attention for rate control as well 
as anticoagulant therapy. The main modality of treatment   is closure of 
the defect either by Transcatheter technique or by surgery. 
INDICATIONS FOR CLOSURE OF ASD: 
Class I Recommendations:- 
-  Closure either surgically or percutaneously is indicated in the 
presence of Right ventricular and right atrial enlargement with or 
maybe without symptoms. (Evidence: B) 
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-  Sinus venosus type, primum ASD, or coronary sinus type, must be 
repaired surgically only. (Evidence: B) 
 Very small septal defects  < 5 mm and  with nil  evidence of right 
heart volume overload have  no  influence in  the natural history, and 
prognosis and  may not demand  closure unless complicated by 
paradoxical embolism.  
Larger defects with right heart volume overload require early 
closure to prevent complications like:  
Decreased exercise tolerance 
[3,23,24]
 
Atrial arrhythmias  
Embolic complications in pregnancy, Paradoxical embolism 
[6]
 
Tricuspid regurgitation 
Intractable cardiac failure
 [7]
 
Right Left shunt 
 Most of the secundum defects could be successfully closed
 [5]
 
through   percutaneous transcatheter method. When this method is not 
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amenable because of deficiency or inadequacy of rims, or too large for 
device closure, surgery is recommended. 
 A multi fenestrated septum or a secundum defect with a large 
septal aneurysm
[26]
 requires meticulous evaluation by experts in the field 
of interventional cardiology before device closure is undertaken as the 
modality of repair. In our study two patients one with a large septal 
aneurysm and the other with multiple defects in the septum have 
undergone successful device closure.   
CRITERIA FOR IDEAL ASD DEVICE CLOSURE:  
•  Within the middle of fossa ovalis  
•  Native size x 1.5 + 14 mm < septal length (LA) 
•  Sufficient rims: 
–  Antero Inferior  Mitral rim 
–  Antero Superior.  Aortic valve rim 
–  Postero Inferior  IVC rim 
–  Postero Superior  Right pulmonary venous rims 
–  Posterior venous rim SVC rim 
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 In many of the institutes in the world, the preferred option for 
secundum defects is device closure 
[45,46]
. Trans-catheter closure reduces 
the  hospital stay  significantly and  offers  a  speedy  recovery, avoidance 
of surgical scars and their  distressing  complications
[29,30,31,32,33]
, cosmetic 
benefit,  and  provides  the  same  or  equivalent hemodynamic benefits as 
that of surgery.
[7,8,35]
 
INDICATIONS FOR SURGICAL CLOSURE: 
Secundum defects > 36 mm 
Primum defects 
Sino venosus defect 
Deficient septal rims 
Close proximity and risk of impingement on AV valves, SVC, IVC, 
Pulmonary veins and coronary sinus 
COMPLICATIONS THAT CAN BE ENCOUNTERED IN DEVICE 
CLOSURE: 
Device embolization usually within 20 minutes of procedure 
[48] 
Cardiac perforation 
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Residual shunts 
Erosion of the aortic root 
Impingement on systemic and pulmonary vein 
Malfunction of the AV valve causing mitral regurgitation 
Pericardial effusion/tamponade 
Perforation of wall of atrium 
Arrhythmias 
Sizing balloon rupture 
Complications of vascular access 
RA –Structures getting entrapped 
Defect/Device mismatch 
Heart blocks due to encroachment on conduction system 
Aortic Regurgitation  
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INDICATIONS FOR SURGICAL CLOSURE: 
 Secundum Defects > 36 mm
[49] 
 Primum defects  
 Sino venosus defect 
 Deficient   septal rims  
 Close proximity with risk of impingement on AV valves, SVC, 
 IVC, Pulmonary veins and coronary sinus 
 Successful device closure is usually achieved in more than 95% of 
individuals, 
[34,50]
 Trans catheter device closure of secundum defects has 
an early, faster, and favourable and effect on cardiac remodeling
[51,52,53,54]. 
 
Individuals following device closure need a thorough clinical 
assessment, echocardiographic screening of pulmonary artery pressures, 
Right heart function[13], and monitoring complications, prior to 
discharge and during early follow-up visits. There is no clear–cut 
consensus regarding as to what constitutes appropriate follow-up of 
patients after ASD device closure.   
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 We evaluated patients prior to device closure and monitored them 
during procedure and immediately post procedure and follow- up echo 
was done at one week and after 3 months. We also compared the results 
with that of surgical closure.  
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MATERIALS AND METHODS 
 All patients with ostium secundum ASD referred for closure were 
analyzed.  Both male and female patients are selected for the study. 
Relevant history, clinical examination, Pulse oximetry, Xray chest, and 
E.C.G were taken for all the patients.  
 All the patients underwent detailed transthoracic and 
transesophageal echocardiographic study. Echocardiogram was done 
using Philips HD7XE Echocardiographic machine. The size, site, and 
number and associated septal aneurysm were well evaluated. Those 
suitable for device closure were meticulously assessed for adequacy of 
rims. Those not suited for device closure due to floppy or inadequacy of 
rims was referred for surgical closure.  
 The following echocardiographic parameters were measured. We  
evaluated right atrial dimensions using major and minor dimensions, and 
right ventricular dimensions using basal, mid and longitudinal diameters, 
main pulmonary artery dimension (MPA), right ventricular systolic 
function using Tricuspid annular plane systolic excursion (TAPSE), 
Myocardial performance index of right ventricle (MPI), and iso-
volumetric acceleration  (IVA), Tricuspid regurgitation peak gradient 
(TRPG), prior to device closure and post device closure immediately, and 
30 
 
at one week, and three months  using 2D, M-Mode colour doppler, 
continuous wave doppler, pulse wave and tissue doppler methods and 
compared them with age and defect size matched individuals who 
underwent  surgical closure.  
STUDY DESIGN: Observational study. 
TOTAL NUMBER OF PATIENTS INCLUDED IN THE STUDY-60 
[30 - device closures, 30 - surgical closures]  
INCLUSION CRITERIA:   
         1. Ostium secundum ASD >12 mm 
         2. Normal biventricular function 
         3. LeftRight shunts  
EXCLUSION CRITERIA: 
        1. Patients with primum or sinus venosus defect. 
2. Irreversible pulmonary artery hypertension. 
3. Patients with other associated shunts (VSD/PDA) . 
4. Patients with a major non-cardiovascular disease . 
5. Age less than 12 years 
6. Patients with coronary artery disease  
7. Unwilling to give consent  
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RESULTS AND DATA ANALYSIS 
 Among the 30 patients optimally selected for ASD device closure 
by percutaneous transcatheter method after fulfilling the inclusion and 
exclusion criteria the baseline characteristics are discussed. 
AGE distribution for device closure - 15 to 55 years  
(mean-28.4 years)  
 
 
  
11-20 yrs 21-30 yrs 31-40yrs >41yrs 
Number  6 13 6 5 
0 
2 
4 
6 
8 
10 
12 
14 
Age Distribution    
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SEX Distribution – Males-8 (27%); Females-22 (73%) 
 
 
PRE-CLOSURE NYHA FUNCTIONAL CLASS- III (15 patients) 
POST DEVICE CLOSURE OUTCOME   
CLASS IIIII (15 patients) 
 
 
  
27% 
73% 
Sex Distribution  
Male 
Female 
0 
2 
4 
6 
8 
10 
12 
14 
16 
PRE CLOSURE NYHA 
III POST CLOSURE 
NYHA III POST CLOSURE 
NYHA II 
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PRE-CLOSURE NYHA FUNCTIONAL CLASS – II (15 patients) 
POST DEVICE CLOSURE OUTCOME  
CLASS III (12 patients) 
 
 
 
FINAL OUT-COME OF NYHA FUNCTIONAL CLASS 
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 The mean  defect size was 17.06±1.855 SD. The mean device 
size was 21±1.80 SD  
 Repeated measure ANOVA is applied to  compare the  pre closure, 
post closure, immediate, 1 week and 3 months  of the right heart 
dimension and function parameters 
The RV BASAL Diameter pre and post device closure values are 
tabulated: 
 N 
Minim
um 
(cms) 
Maxim
um 
(cms) 
Mean 
Std. 
Deviation 
RVB-
preclosure 
30 3.9 4.6 4.297 .1847 
RVB- 
postclosure 
immediate 
30 2.7 3.8 3.167 .2202 
RVB- 
postclosure   
1 week 
30 2.7 3.7 3.167 .2233 
RVB- 
postclosure 
3months 
30 .0 3.6 2.893 .5813 
 
 There is significant difference between 4 time occasions, 
F=164.228, P<0.001. Further multiple comparison of occasions shows all 
pairs are significantly different at 0.05 level. 
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The RV mid cavity diameter pre and post device closure is tabulated: 
 
 N 
Mini
mum 
(cms) 
Maxi
mum 
(cms) 
Mean 
Std. 
Deviatio
n 
RVMid 
preclosure 
30 2.8 4.0 3.610 0.2551 
RVMid 
post closure 
immediate 
30 1.6 3.8 3.027 0.3562 
RVMid 
postclosure 
1 week 
30 1.7 3.7 2.877 0.3411 
RVMid 
postclosure 
3months 
30 1.5 3.5 2.710 0.3458 
 
 There is significant difference between 4 time occasions, 
F=359.324, P<0.001. 
 Further multiple comparison of occasions shows all pairs are 
significantly different. 
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RV Longitudinal dimensions measured pre and post device closure: 
 N 
Mini
mum 
(cms) 
Maxi
mum 
(cms) 
Mean 
Std. 
Deviation 
RVL 
preclosure 
30 8.0 8.9 8.647 0.2374 
RVL 
postclosure 
immediate 
30 5.2 7.0 6.310 0.4536 
RVL 
postclosure 
1week 
30 4.9 6.8 6.070 0.4757 
RVL 
postclosure 
3months 
30 4.8 6.9 5.963 0.4867 
 
There is significant  difference between  4 time occasions, F=509.617, 
P<0.001. 
Further multiple comparison of occasions shows  all pairs are 
significantly different. 
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PRE ASD DEVICE CLOSURE RV DIMENSIONS 
 
POST ASD DEVICE   CLOSURE IMMEDIATE-IMPACT ON RV 
DIMENSIONS
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COMPARISON OF PRE AND POST CLOSURE RV DIMENSIONS 
 
The right atrial major dimensions in (cms) pre and post device 
closure results: 
 N 
Mini
mum 
Maxi
mum 
Mean 
Std. 
Deviatio
n 
RA MAJOR 
preclosure 
30 5.1 5.6 5.350 .1408 
RA MAJOR-
post closure 
immediate 
30 4.1 5.2 4.653 .3501 
RA MAJOR 
post closure 
1week 
30 4.0 5.1 4.450 .3893 
RA MAJOR-
post closure 
3months 
30 3.9 5.0 4.283 .3742 
There is significant difference between 4 time occasions, F=180.003, 
P<0.001. 
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9 
RV BASAL RV MID RV 
LONGITUDINAL  
PRE CLOSURE 
POST CLOSURE IMMEDIATE 
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PRE CLOSURE RIGHT ATRIAL MAJOR AND MINOR 
DIMENSIONS 
 
POST  DEVICE CLOSURE IMMEDIATE IMPACT ON RIGHT 
ATRIAL DIMENSION   
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RIGHT ATRIAL MINOR DIMENSIONS IN (CMS) PRE AND 
POST DEVICE CLOSURE RESULTS: 
 N 
Mini
mum 
Maxi
mum 
Mean 
Std. 
Deviation 
RA MINOR 
preclosure 
30 3.9 5.0 4.547 0.2933 
RA MINOR 
postclosure 
immediate 
30 2.8 4.9 3.870 0.5266 
RA MINOR 
postclosure  
1 week 
30 2.7 4.8 3.710 0.5155 
There is significant difference between 4 time occasions, F=58.655, 
P<0.001.  
FINAL OUTCOME OF RIGHT ATRIAL DIMENSIONS  PRE AND 
POST ASD DEVICE CLOSURE
 
 
0 
1 
2 
3 
4 
5 
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RA MAJOR DIMENSION RA MINOR 
PRE CLOSURE 
POST CLOSURE IMMEDIATE 
POST CLOSURE 1 WEEK 
POST CLOSURE 3 MONTH 
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Main pulmonary artery dimensions in (cms) pre and post device 
closure: 
 N 
Mini
mum 
Maxi
mum 
Mean 
Std. 
Deviatio
n 
MPA 
diameter 
preclosure 
30 2.5 3.5 2.960 0.2094 
MPA 
diameter 
postclosure 
immediate 
30 2.2 3.1 2.640 0.1958 
MPA 
diameter 
post closure 
1 week 
30 2.1 3.0 2.533 0.2073 
MPA 
diameter 
postclosure 
3 months 
30 2.0 2.6 2.310 0.1768 
 
There is significant difference between 4 time occasions, F=444.425, 
P<0.001. 
Further multiple comparison of occasions shows all pairs are significantly 
different 
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PRE CLOSURE MPA DIMENSIONS 
 
POST ASD DEVICE CLOSURE MPA DIMENSIONS 
IMMEDIATE 
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FINAL OUTCOME OF MPA DIMENSIONS PRE AND POST 
DEVICE CLOSURE:  
 
COMPARISON OF TR PEAK GRADIENT PRE AND POST ASD 
DEVICE CLOSURE: 
 N 
Minimum 
mmHg 
Maximu
m 
mmHg 
Mean 
Std. 
Deviation 
TRPG 
preclosure 
30 20.0 52.0 45.700 6.3145 
TRPG 
postclosure 
immediate 
30 9.7 32.0 24.523 4.6248 
TRPG 
postclosure 
1 week 
30 12.0 26.0 21.467 2.6488 
TRPG 
postclosure 
3months 
30 9.0 24.0 19.233 3.0021 
 
There is significant difference between 4 time occasions, F=509.363, 
P<0.001. 
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COMPARISON OF TR PEAK GRADIENT PRE AND POST ASD 
DEVICE CLOSURE 
 
COMPARISON OF TAPSE in mm PRE AND POST DEVICE 
CLOSURE: 
 
 N 
Mini
mum 
Maxi
mum 
Mean 
Std. 
Deviatio
n 
TAPSE 
preclosure 
30 23.0 29.0 25.367 1.6501 
TAPSE 
postclosure 
immediate 
30 20.0 26.0 22.833 1.5105 
TAPSE 
postclosure 
1 week 
30 19.0 24.0 21.500 1.4081 
TAPSE 
postclosure 
3 months 
30 18.0 22.0 19.633 1.2172 
 
There is significant difference between 4 time occasions, F=370.577, 
P<0.001. 
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PRE DEVICE CLOSURE TAPSE 
 
POST ASD DEVICE CLOSURE - IMMEDIATE IMPACT ON 
TAPSE REDUCED FROM 29MM TO 15.1 MM 
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FINAL OUTCOME OF TAPSE PRE AND POST ASD DEVICE 
 
 
COMPARISON OF MYOCARDIAL PERFORMANCE INDEX 
(MPI) PRE AND POST ASD DEVICE CLOSURE: 
 N 
Mini
mum 
Maxi
mum 
Mean 
Std. 
Deviation 
MPI 
preclosure 
30 3.2 4.9 4.113 .4345 
MPI post 
closure 
immediate 
30 3.2 4.9 3.943 .4141 
MPI post 
closure 
 1 week 
30 3.0 4.8 3.653 .5015 
MPI post 
closure 
 3 months 
30 2.7 4.7 3.233 .4823 
 
There is significant difference between 4 time occasions, F=45.367, 
P<0.001 
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FINAL OUTCOME OF MPI PRE AND POST ASD  
DEVICE CLOSURE 
 
COMPARATIVE DATA ON ISOVOLUMIC ACCELERATION 
(ISA) PRE AND POST ASD DEVICE CLOSURE: 
 
 N Mini
mum 
Maxi
mum 
Mean Std. 
Deviation 
ISA pre 
closure 
30 2.5 3.5 2.960 .2253 
ISA post 
closure 
immediate 
30 2.2 3.1 2.643 .2029 
ISA post 
closure 1 
week 
30 2.1 3.0 2.547 .2330 
ISA post 
closure 3 
months 
30 2.1 2.8 2.347 .1925 
 
There is significant difference between 4 time occasions, F=228.286, 
P<0.001. 
Further multiple comparison of occasions shows all pairs are significantly 
different. 
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ISOVOLUMIC ACCELERATION IS MEASURED BY FINDING 
THE QUOTIENT OF ISOVOLUMETRIC ACCELERATION 
VELOCITY DIVIDED BY TIME 
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ISOVOLUMIC ACCELERATION POST ASD DEVICE CLOSURE 
IMMEDIATE  
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Surgical closure patients mean and standard deviation of age 
distribution and defect size: 
 N 
Minim
um 
Maxi
mum 
Mean 
Std. 
Deviation 
AGE 30 14.0 59.0 28.467 9.4485 
DEFECT 
SIZE 
30 17.0 26.0 20.633 1.9384 
 
Comparison of age between device closure and surgical closure group  
Student t test is used. 
Group Statistics  
Age 
Group N Mean 
Std. 
Deviation 
t value P value 
Device 
closure 
30 28.400 9.4490 
0.014 
P>0.05 
NS Surgical 
closure 
30 28.367 9.4485 
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Comparison of Device closure and surgical closure group  
Student t test is used to compare mean scores 
Group Statistics   
 GROUP N Mean 
Std. 
Deviati
on 
t 
value 
D
F 
P value 
significance 
RV  
Basal 
dm 
PreDevice 
closure 
30 4.297 .1847 
-
2.582 
58 P=0.012* 
PreSurgical 
closure 
30 4.440 .2415    
RV 
Basal 
dm  
3 
month 
PostDevice 
closure 
30 2.893 .5813 .693 58 P=0.491 NS 
PostSurgical  
closure 
30 2.817 .1724    
RV 
Mid 
PreDevice 
closure 
30 3.610 .2551 
-
1.045 
58 P=0.300 NS 
PreSurgical  
closure 
30 3.677 .2388    
RV 
Mid 
3 
month 
PostDevice 
closure 
30 2.710 .3458 3.155 58 P=0.003* 
PostSurgical  
closure 
30 2.467 .2426    
RVL 
PreDevice 
closure 
30 8.647 .2374 
-
2.978 
58 P=0.004* 
PreSurgical  
closure 
30 8.900 .4009    
RVL 
3 
month 
PostDevice 
closure 
30 5.963 .4867 2.012 58 P=0.049* 
PostSurgical  
closure 
30 5.750 .3170    
RA 
Major 
dm 
PreDevice 
closure 
30 5.350 .1408 4.662 58 P<0.001* 
PreSurgical  
closure 
30 5.060 .3103    
RA 
Major 
dm 3 
month 
PostDevice 
closure 
30 4.283 .3742 1.981 58 P=0.052 NS 
PostSurgical  
closure 
30 4.090 .3818    
  
52 
 
 
Group Statistics   
 GROUP N Mean 
Std. 
Deviati
on 
t 
value 
D
F 
P value 
significance 
RA 
Minor 
dm 
PreDevice 
closure 
30 4.547 .2933 1.617 58 P=0.111 NS 
PreSurgical  
closure 
30 4.427 .2815    
RA 
minor  
dm 
3 
month 
PostDevice 
closure 
30 3.563 .5096 .220 58 P=0.827 NS 
PostSurgical  
closure 
30 3.537 .4263    
TRPG 
PreDevice 
closure 
30 45.700 6.3145 
-
1.361 
58 
P=0.179 
NS 
PreSurgical  
closure 
30 47.500 3.5501    
TRPG 
3 
month 
PostDevice 
closure 
30 19.233 3.0021 
-
1.429 
58 P=0.158 NS 
PostSurgical  
closure 
30 20.200 2.1719    
MPI 
PreDevice 
closure 
30 4.113 .4345 .464 58 P=0.644 NS 
PreSurgical  
closure 
30 4.067 .3387    
MPI 
3 
month 
PostDevice 
closure 
30 3.233 .4823 
-
1.784 
58 
P=.080 
NS 
PostSurgical  
closure 
30 3.447 .4431    
NS NOT SIGNIFICANT 
* SIGNIFICANT 
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FINAL COMPARISON OF OUTCOME BETWEEN DEVICE 
CLOSURE PATIENTS AND SURGICAL GROUP - PRE AND 
POST 3 MONTH ANALYSIS 
 
RV DIMENSIONS: COMPARISON OF SURGICAL AND DEVICE 
CLOSURE OUTCOMES 
 
RIGHT ATRIAL DIMENSIONS: COMPARISON OF SURGICAL 
AND DEVICE CLOSURE OUTCOMES 
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NO EVIDENCE OF PARADOXICAL SEPTAL MOVEMENT IN 
THE POST DEVICE CLOSURE PERIOD 
 
 
Among the 30 patients referred for surgical closure was successful in 
all of them except in one patient who developed pericardial patch 
dehiscence at 3 months follow up period 
PERICARDIAL PATCH DEHISCENCE IN 1 POST SURGICAL 
PATIENT 
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DISCUSSION 
 This study was mainly undertaken to establish the beneficial effects 
of percutaneous transcatheter device closure in optimally selected patients 
with ostium septum defects and the impact of device closure on the right 
heart dimensions and functions. 
 Among the 32 patients selected for device closure, 12 patients with 
deficient aortic rims ,one patient with atrial septal aneurysm, and  
1 patient with multiple secundum defects, we were successful in 
deploying the amplatzer septal occluder
[5,4]
,in 4 patients,andcocoon septal 
occluder in 26 patients. 2 patients were deferred after an attempt due to 
floppy IVC rims. All the 30 patients who underwent successful device 
closure were closely observed pre procedurally with transthoracic and 
transesophageal echo, and during procedure with TEE, and post 
procedurally immediately, after 1 week, and after 3 months. None of the 
procedural or post procedural complications like device embolisation, 
erosion, or heart blocks noted in our patients, except that 4 patients had 
transient atrial arrhythmias during the procedure which  spontaneously 
reverted in 2 of them, and which necessitated adenosine for reversion to 
sinus rhythm in 2 patients. Arrhythmias were not encountered in any of 
them in the post procedure follow up period.  
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 The minimum fluoroscopic time was 8 minutes and the maximum 
fluoroscopic time was 48 minutes and the mean fluoroscopic time was  
28 minutes ±7 minutes. Balloon sizing was done for 3 patients. In 28 
patients the device was deployed by parking the multipurpose catheter 
and 0.035” terumo guide wire in the left upper pulmonary vein and in two 
patients in the right upper pulmonary vein. 
 All patients received 100 units/kg of unfractionated heparin during 
the procedure and preprocedure 300 mg of aspirin which was continued 
as 150 mg /day following the procedure for 6 months period.  
No thromboembolic complications were noted in our patients. 
 All patients were discharged on the third post intervention day. The 
right atrial major and minor dimensions and right ventricular basal, 
midcavity and longitudinal dimensions ,main pulmonary artery 
dimensions, pulmonary hypertension as assessed by TRPG, were noted in 
the pre procedure period  and  immediately after the procedure, and   
1 week, and at 3 months follow up period. Likewise RV systolic 
functions were assessed using TAPSE, MPI and isovolumetric 
acceleration. 
 Statistical analysis revealed that the mean age for device closure 
was 28.4(range between 15-55 years.) Females dominated the sex 
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distribution contributing to 73% and males 23%. The NYHA functional 
class improved by one functional class in 90% of the individuals. The 
preprocedural mean RA major and minor dimensions and RV dimensions 
were significantly reduced by device closure, in the immediate, 1 week 
and after 3 months of followup. The reduction in right heart dimensions 
were consistent in the immediate post intervention period, which showed 
further reduction at 3 months  and was statistically significant. Pulmonary 
hypertension almost normalized in all the patients at 3 months of 
followup. There was a gradual decline in the TRPG during the follow up 
period from 45.7±6.37 mmHg to 19.23±3 mmHg which was statistically 
significant. The MPA dimensions reduced from a mean diameter of 2.96 
cm to 2.31 cm which is statistically significant.   
 Actually TAPSE a marker of RV systolic function though 
remained normal throughout the study period, reduced from a mean value 
of 25.36 mm to 19.6 mm which is statistically significant. The reduction 
in TAPSE could well be explained by the fact that during the 
preprocedure period when the volume overload to the RV is more the 
tricuspid annular excursion is more so that it can offload the overloaded 
right heart, whereas during the post intervention period the closure of the 
septal defect halts the gushing of blood into the right heart system thus 
not requiring the excessive tricuspid annular excursion.             
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MPI though within normal limits throughout the study period 
significantly improved in the post closure period. 
 Isovolumic acceleration a load independent determinant of  
RV systolic function remains stable or improves following device 
closure. The outcome was better in individuals in whom the defect was 
closed at an earlier age than those closed at a later age group [Better 
outcome in age less than 20 years when compared to age > 40 years 
matched by defect size].This could well explain the chronological impact 
of volume overload on the right heart and its thrust on the remodeling and 
hemodynamics of right heart dimension and function. The results of 
device closure at 3 months follow up when compared to age and defect 
size, matched surgical closure results in 30 patients and were not 
statistically significant proving the outcome of transcatheter closure non 
inferior to surgical closure of ASD.  
 All patients had normal LV systolic function at follow up of  
3 months but all patients in the surgical closure group had abnormal or 
paradoxical ventricular septal motion. Among the 30 patients who 
underwent surgical closure successfully only one patient had pericardial 
patch dehiscence at 3 months follow up 
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Comparison of our study with other published data: 
 In one study by salehain et al 
[14]
 which proved improvement of  
RV function and performance after device closure of septum secundum 
defects.  
 But in another study by Eidem et al
[11]
 did not report on 
improvement of right heart function. Giardini et al 
[42]
 showed 
improved LV systolic function due to normalization of paradoxical septal 
motion after device closure.  
 Another study by kort et al
[28]
 which demonstrated decrease in  
RA area and RV dimensions followed up in 24 hrs, 1 month and  
3 months period and 2 years followup. A recent study published in 
Am.JAC, 2012 which compares the outcome of surgical versus device 
closure in adults closely resembles our study. 
 Percutaneous device closure outweighs surgical closure in the 
following  
ways:  
1.  No Scar 
2.  Lesser hospital stay (3 days) 
3.  Less Morbidity 
4.  Avoiding opening of the pericardium as in surgical closure thus 
 preventing abnormal/paradoxical ventricular septal motion.  
5.  Avoidance of thoracotomy and its complications 
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Unique features pertinent to our study: 
 Most of the studies failed to unravel the outcome of right heart 
hemodynamics, function and dimension in the immediate post device 
closure period, which is very well evaluated in our study the first of its 
kind.  
 Most of the data published so far either took into account the right 
heart dimensions alone, or right heart functions only, or compared them 
with surgical closure. Our study is a Comprehensive one which 
encompasses most of the aspects of impact of device closure on right 
heart dimensions and functions, MPA dimensions, reversal of pulmonary 
hypertension, and comparative analysis with that of surgical closure. 
 There are only a very few data on isovolumetric acceleration a 
volume load independent new marker of RV systolic function which is 
studied in detail in our study. 
 The impact of device closure on TAPSE has not well been 
established, and our study provides insight into the decrease of TAPSE, 
following closure which is well again a hitherto documentation. 
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CONCLUSION 
 
 We conclude that percutaneous transcatheter device closure is a 
reliable, safe and cost effective option for ideally selected Ostium 
Secundum defect patients. 
 
 The maximum beneficial effects on right heart functions, dimensions 
and remodeling begins immediately after device closure and the 
continued benefit is observed even at three months 
 
 The beneficial impact on functional capacity, right heart dimensions, 
functions and hemodynamics are comparable and non inferior to 
surgical closure patients. 
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LIMITATIONS OF THE STUDY 
 
1.  Estimation of right heart volumes not done. 
2.  RV diastolic function not assessed. 
3.  Long term outcome is still under evaluation and hence not included 
 in the study. 
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 ABBREVIATIONS  
 
 ANOVA, analysis of variance;  
 ASD, atrial septal defect 
 Qp, pulmonary blood flow;  
 Qs, systemic blood flow;  
 RA, right atrium;  
 RV, right ventricle;  
 RVEDD, right ventricular end-diastolic dimension 
 IVA = Isovolumic acceleration 
 MPI = Myocardial performance index 
 LV = Left ventricle 
 MPA = Main Pulmonary artery 
 PH T = Pulmonary hypertension 
 RIMP = Right ventricular index of myocardial performance 
 SD = Standard deviation 
 TAPSE = Tricuspid annular plane systolic excursion 
 TR = Tricuspid regurgitation 
 2D = Two-dimensional 
 
PROFORMA-BASE LINE CHARACTERISTICS 
 
  
 
 
 
 
 
 
 
 
 
AGE  
SEX  
NYHA CLASS 
 
 
PRE ASD 
DEVICE 
CLOSURE 
Post ASD DEVICE 
CLOSURE 
(IMMEDIATELY) 
Post ASD 
DEVICE 
CLOSURE 
1-WEEK  
Post ASD 
DEVICE 
CLOSURE 
3-MONTHS 
    
HYPERTENSION  
 DM  
ATRIAL SEPTAL DEFECT 
SIZE 
 
RIMS  
DEVICE SIZE  
ECG PRE ASD 
DEVICE 
CLOSURE 
Post ASD DEVICE 
CLOSURE 
(IMMEDIATELY) 
Post ASD 
DEVICE 
CLOSURE 
1-WEEK  
Post ASD 
DEVICE 
CLOSURE 
3-MONTHS 
    
  
 
 
 
 
 
 
ECHOCARDIOGRAPHIC ASSESSMENT 
 PRE ASD 
DEVICE 
CLOSURE 
Post ASD 
DEVICE 
CLOSURE 
(IMMEDIATELY) 
Post ASD 
DEVICE 
CLOSURE 
1-WEEK 
Post ASD 
DEVICE 
CLOSURE 
3-MONTHS 
CHAMBER 
QUANTIFICATION 
    
RV BASAL (RV D1)     
RV MID (RV D2)     
RV 
LONGITUDINAL 
(RV D3) 
    
RA MAJOR 
DIMENSION 
    
RA MINOR 
DIMENSION 
    
MPA SIZE     
RVOT  PV/PG     
TAPSE     
MPI     
TR / PG     
IVA     
 
Parasternal long axis (PLAX), Parasternal short axis (PSAX), Main pulmonary artery (MPA), 
Tricuspid annular planar systolic excursion (TAPSE), Myocardial performance index (MPI), 
Fractional area change(FAC), Tricuspid regurgitation peak gradient (TRPG), RT ventricle 
Isovolumetric acceleration (RV IVA). 
  
 Information sheet 
 We are conducting a study of the " Assessment of Right Heart function 
and dimension following device closure of Atrial Septal Defect ’’at the 
Department of Cardiology ,Rajiv Gandhi Govt. General Hospital, Chennai. 
The purpose of this study is to assess right heart function, right atrial  and 
right ventricular  dimensions after transcatheter closure of atrial septal 
defect (ASD) and to investigate factors that may predict magnitude of 
resolution of right heart enlargement by echocardiography using 2D and 
tissue doppler imaging .  
 
 The privacy of the patients in the research will be maintained throughout 
the study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time. Your decision will not 
result in any loss of benefits to which you are otherwise entitled. 
 
  The results of the study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in 
the management or treatment. 
 
 
 Signature of the investigator                          Signature of the participant 
 
 
 
 
 
 
 
  
PATIENT CONSENT FORM 
Study Details : Assessment of Right Heart function and dimension  
   following device closure of Atrial Septal Defect  
 
Study Centre  : Department of Cardiology, 
   Madras Medical College and  
   Rajiv Gandhi Government General Hospital,  
   Chennai - 600 003. 
 
Patient may check ( ) these boxes: 
 
I confirm that I have understood the purpose of procedure for the above study. I have 
the opportunity to ask question and all my questions and doubts have been answered to my 
complete satisfaction. 
 
I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being affected. 
 
I understand that the investigator of the clinical study, others working on his behalf, 
the ethical committee and the regulatory authorities will not need my permission to look at 
my health records, both in respect of current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study. However, I understand that my 
identity will not be revealed in any information released to third parties or published, unless 
as required under the law. I agree not to restrict the use of any data or results that arise from 
this study. 
 
I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully cooperate with the study team and to immediately inform the 
study staff if I suffer from any deterioration in my health or well being or any unexpected or 
unusual symptoms. 
 
I hereby give permission to undergo complete clinical examination and diagnostic 
tests including hematological, biochemical, ECG, Echocardiography  appropriate to the 
clinical diagnosis. 
 
 I hereby consent to participate in this study. 
 
Signature / Thumb impression:                                               Place :  Date : 
 
 
Patient Name and Address:    
 
Signature of Investigator:                                                            Place :Date : 
Study Investigator’s Name :         
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